ĀÜĄņĀŅĀ×

Matthew S. Gregorio MA, CCRC has over 16 years of experience in the clinical research field. In 2020, they began working as a Senior Clinical Project Manager at Nocion Therapeutics, Inc., a Clinical Trial Management Consultant at Aldeyra Therapeutics, and a Consulting Clinical Trial Manager at Talaris Therapeutics. From 2015 to 2020, they were an Associate Clinical Project Manager at Acorda Therapeutics, Inc., where they were a key contributor in the Phase3 Parkinsonā€™s Disease Program, which led to successful 505(b)(2) submission and FDA approval for INBRIJAā„¢ (levodopa inhalation powder) drug/devise combination product, as well as the successful MMA filing and approval in the EU. From 2013 to 2015, they were a Clinical Research Coordinator (Research Assistant II) at Brigham and Women's Hospital, where they were the lead clinical research coordinator of the ā€œOptimizing Protein in Older Americans with Mobility Limitationsā€ (OPTIMen) Study. From 2012 to 2013, they were a Clinical Research Assistant/Clinical Research Coordinator at Boston Medical Center. Prior to that, they were an Ophthalmic Medical Technician at Jason M Gilbert MD PC from 2008 to 2012 and an Ophthalmic Medical Assistant at Stephen J. Poor III MD PC from 2004 to 2008.

Matthew S. Gregorio MA, CCRC obtained a Bachelor of Science (B.S.) in Biology, General from the University of Massachusetts Amherst between 1999 and 2003. Matthew S. then attended Boston University from 2006 to 2013, earning a Master of Arts (M.A.) in Medical Sciences and a Master of Arts (M.A.), Clinical Investigation in Clinical Research. In 2014, they became a Member of the Association of Clinical Research Professionals. In 2015, they were awarded the Certified Clinical Research Coordinator (CCRC\u00ae) certification from the Association of Clinical Research Professionals.